Skip to main content
Clinical Trials/CTRI/2020/09/027536
CTRI/2020/09/027536
Not yet recruiting
未知

A prospective randomized clinical study to compare efficacy of intravenous ringer lactate or diclofenac suppository or combination of both in prevention of post endoscopic retrograde cholangio-pancreatography(ERCP) pancreatitis.

Department of Gastroenterology0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: K87- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere
Sponsor
Department of Gastroenterology
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients having high risk factors for post ERCP pancreatitis.

Exclusion Criteria

  • Patient with contraindication for diclofenac and ringer lactate,
  • Patient with active acute pancreatitis,
  • Patient not giving consent

Outcomes

Primary Outcomes

Not specified

Similar Trials